All Stories

  1. Prospective cohort study of unselected nulliparous women with a nested randomised controlled trial of screening using the sFLT1:PlGF ratio, ultrasound and maternal characteristics and intervention using enhanced monitoring and early delivery: study pro...
  2. A prospective cohort study of unselected nulliparous women with a nested randomized controlled trial of screening using the sFLT1:PlGF ratio, ultrasound and maternal characteristics and intervention using enhanced monitoring and early delivery: study p...
  3. Towards microbiome-informed strategies for predicting and preventing pregnancy complications
  4. Deciphering Roles of Placental Endoplasmic Reticulum Stress in Complicated Pregnancies and Beyond: The Power of Mouse Models
  5. The human placenta and its role in reproductive outcomes revisited
  6. Raised Leptin and Pappalysin2 cell-free RNAs are the hallmarks of pregnancies complicated by preeclampsia with fetal growth restriction
  7. Genetic Variants Associated With Preeclampsia and Maternal Serum sFLT1 Levels
  8. Single-cell RNA sequencing identifies CXADR as a fate determinant of the placental exchange surface
  9. GDF15 linked to maternal risk of nausea and vomiting during pregnancy
  10. Longitudinal profiling of the pregnancy plasma proteome through organic solvent precipitation and nano LC-MS/MS
  11. Placental Streptococcus agalactiae DNA is associated with neonatal unit admission and foetal pro-inflammatory cytokines in term infants
  12. Prediction of spontaneous preterm birth using supervised machine learning on metabolomic data: A case–cohort study
  13. Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study
  14. Objective measures of smoking and caffeine intake and the risk of adverse pregnancy outcomes
  15. Protocol for culturing the endocrine junctional zone of the mouse placenta in serum-free medium
  16. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth
  17. The human placenta exhibits a unique transcriptomic void
  18. Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy
  19. Group B Streptococcus and the risk of perinatal morbidity and mortality following term labor
  20. Physiologically relevant culture medium Plasmax improves human placental trophoblast stem cell function
  21. Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction
  22. Perturbation of placental protein glycosylation by endoplasmic reticulum stress promotes maladaptation of maternal hepatic glucose metabolism
  23. The human placenta exhibits a unique transcriptomic void
  24. Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress
  25. Placental sex-dependent spermine synthesis regulates trophoblast gene expression through acetyl-coA metabolism and histone acetylation
  26. Metabolomic Identification of a Novel, Externally Validated Predictive Test for Gestational Diabetes Mellitus
  27. Author Correction: Inherent mosaicism and extensive mutation of human placentas
  28. Erratum to: A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study
  29. Placental energy metabolism in health and disease—significance of development and implications for preeclampsia
  30. A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study
  31. Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor
  32. Placental polyamines regulate acetyl-coA and histone acetylation in a sex-specific manner
  33. RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first–second trimester transition
  34. Inherent Mosaicism and Extensive Mutation of Human Placentas
  35. The RNA landscape of the human placenta in health and disease
  36. Inherent mosaicism and extensive mutation of human placentas
  37. Somatic mutations reveal widespread mosaicism and mutagenesis in human placentas
  38. Batch effects account for the main findings of an in utero human intestinal bacterial colonization study
  39. Abnormal placental CD8 + T‐cell infiltration is a feature of fetal growth restriction and pre‐eclampsia
  40. Evolutionary History of Endogenous Human Herpesvirus 6 Reflects Human Migration out of Africa
  41. Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia
  42. A high-throughput platform for detailed lipidomic analysis of a range of mouse and human tissues
  43. A maternal serum metabolite ratio predicts fetal growth restriction at term
  44. P112 Activation of PIK3CA in a model of endometriosis may shed light on the pathogenesis of ovarian clear cell adenocarcinoma
  45. Author Correction: Human placenta has no microbiome but can contain potential pathogens
  46. IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery
  47. Role of soluble endoglin in BMP9 signaling
  48. Three-dimensional morphological analysis of placental terminal villi
  49. Human placenta has no microbiome but can contain potential pathogens
  50. The International Network for Evaluating Outcomes (iNeo) of neonates: evolution, progress and opportunities
  51. The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome
  52. 4-Hydroxyglutamate is a novel predictor of pre-eclampsia
  53. Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer’s-associated amyloid beta peptide
  54. A lower maternal cortisol to cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks
  55. 440: Low cortisol to cortisone ratio precedes pre-eclampsia (PE) and fetal growth restriction (FGR)
  56. Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice
  57. Correction to: Detecting eukaryotic microbiota with single-cell sensitivity in human tissue
  58. Detecting eukaryotic microbiota with single-cell sensitivity in human tissue
  59. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study
  60. ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
  61. Recognizing the reagent microbiome
  62. Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice
  63. Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
  64. Estimating neonatal length of stay for babies born very preterm
  65. Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta
  66. Retosiban Prevents Stretch-Induced Human Myometrial Contractility and Delays Labor in Cynomolgus Monkeys
  67. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers
  68. Birth weight to placenta weight ratio and its relationship to ultrasonic measurements, maternal and neonatal morbidity: A prospective cohort study of nulliparous women
  69. Age at menarche and the risk of operative delivery
  70. RNA-Seq reveals conservation of function among the yolk sacs of human, mouse and chicken
  71. RNA-seq reveals conservation of function among the yolk sacs of human, mouse, and chicken
  72. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor RatioNovelty and Significance
  73. 155: Screening for late fetal growth restriction using ultrasound and the sFlt-1:PlGF ratio
  74. Computational modeling of the structure-function relationship in human placental terminal villi
  75. Fetus-derived DLK1 is required for maternal metabolic adaptations to pregnancy and is associated with fetal growth restriction
  76. The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes
  77. Three-dimensional modeling of human placental terminal villi
  78. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia
  79. The relationship between human placental morphometry and ultrasonic measurements of utero-placental blood flow and fetal growth
  80. Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications
  81. Leptin Matures Aspects of Lung Structure and Function in the Ovine Fetus
  82. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma
  83. Age‐related changes in murine myometrial transcript profile are mediated by exposure to the female sex hormones
  84. The Effect of an Oxytocin Receptor Antagonist (Retosiban, GSK221149A) on the Response of Human Myometrial Explants to Prolonged Mechanical Stretch
  85. Morphological and molecular changes in the murine placenta exposed to normobaric hypoxia throughout pregnancy
  86. Developmental Expression and Glucocorticoid Control of the Leptin Receptor in Fetal Ovine Lung
  87. The acute-phase protein SAA3 is present in the preterm human colostrum and breast milk
  88. Energy status and HIF signalling in chorionic villi show no evidence of hypoxic stress during human early placental development
  89. Endoplasmic reticulum stress regulates placental growth factor expression in human choriocarcioma cells
  90. 3D surface reconstruction of human terminal villi and the fetal capillary bed
  91. Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early‐ and late‐onset pre‐eclampsia
  92. Influence of speed of sample processing on placental energetics and signalling pathways: Implications for tissue collection
  93. Phosphorylation changes in survival and stress-response signalling pathways in the human placenta as an artefact of delayed tissue collection
  94. Redefining Preeclampsia Using Placenta-Derived Biomarkers
  95. Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis
  96. Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction
  97. Expression of gastrin‐releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility
  98. Proceedings of Research in Clinical Practice 2011
  99. A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles
  100. Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A–1
  101. Gene network inference and visualization tools for biologists: application to new human transcriptome datasets
  102. Disruption of paraoxonase 3 impairs proliferation and antioxidant defenses in human A549 cells and causes embryonic lethality in mice
  103. Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?
  104. Functional analysis of the antioxidant paraoxonase-3 in lung epithelial cells by rna interference
  105. Dynamic expression and steroid regulation of sarg, a novel gene in the perinatal lung
  106. Estimating Genome-Wide Gene Networks Using Nonparametric Bayesian Network Models on Massively Parallel Computers
  107. Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis
  108. Regulation of AKT Phosphorylation at Ser473 and Thr308 by Endoplasmic Reticulum Stress Modulates Substrate Specificity in a Severity Dependent Manner
  109. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo
  110. MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms
  111. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling
  112. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  113. VEGF-A loss in the haematopoietic and endothelial lineages exacerbates age-induced renal changes
  114. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine
  115. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  116. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  117. Paraoxonase-3, a Putative Circulating Antioxidant, Is Systemically Up-Regulated in Late Gestation in the Fetal Rat, Sheep, and Human
  118. VEGF-A and Serum Withdrawal Induced Changes in the Transcript Profile in Human Endometrial Endothelial Cells
  119. Antivascular and anticancer activity of dihalogenated A-ring analogues of combretastatin A-4
  120. The influence of the intrauterine environment on human placental development
  121. Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium
  122. Regulation of vascular growth and function in the human placenta
  123. Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys
  124. Analysis of PPARα-dependent and PPARα-independent transcript regulation following fenofibrate treatment of human endothelial cells
  125. Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia
  126. Characterization of Serotonin Receptors in Pregnant Human Myometrium
  127. Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction study
  128. UNRAVELING DYNAMIC ACTIVITIES OF AUTOCRINE PATHWAYS THAT CONTROL DRUG-RESPONSE TRANSCRIPTOME NETWORKS
  129. Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment
  130. Evidence of Placental Translation Inhibition and Endoplasmic Reticulum Stress in the Etiology of Human Intrauterine Growth Restriction
  131. Transcript profile and localization of Wnt signaling–related molecules in human endometrium
  132. The Effect of Delaying Childbirth on Primary Cesarean Section Rates
  133. Stimulation of Contractions in Human Myometrium by Serotonin is Unmasked by Smooth Muscle Relaxants
  134. Statistical inference of transcriptional module-based gene networks from time course gene expression profiles by using state space models
  135. Localization and Control of Expression of VEGF-A and the VEGFR-2 Receptor in Fetal Sheep Intestines
  136. Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration
  137. 325: Maternal age and uterine function: A biological basis for rising rates of cesarean delivery
  138. Oxidative Stress, Gene Expression, and Protein Changes Induced in the Human Placenta during Labor
  139. Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?
  140. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium
  141. Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment
  142. Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta)
  143. Nuclear Factor-κB, p38, and Stress-Activated Protein Kinase Mitogen-Activated Protein Kinase Signaling Pathways Regulate Proinflammatory Cytokines and Apoptosis in Human Placental Explants in Response to Oxidative Stress
  144. Human Early Placental Development: Potential Roles of the Endometrial Glands
  145. Quantitative Cellular and Molecular Analysis of the Effect of Progesterone Withdrawal in a Murine Model of Decidualization
  146. Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells
  147. Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2
  148. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia
  149. In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer
  150. Changes in Gene Expression during Wolffian Duct Development
  151. Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT
  152. COMPUTATIONAL STRATEGY FOR DISCOVERING DRUGGABLE GENE NETWORKS FROM GENOME-WIDE RNA EXPRESSION PROFILES
  153. Reply: Is the dose to inhibit the COX-2 enzyme in nude mice also adequate in human endometrial tissues?
  154. Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception
  155. Vascular growth and modelling in the endometrium
  156. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys
  157. Novel antiangiogenic agents for use in contraception
  158. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis
  159. 126. Progesterone regulates CXCL14 (macrophage inflammatory protein 2γ) mRNA in human endometrium
  160. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma
  161. Independent component analysis of microarray data in the study of endometrial cancer
  162. Secretion of Tumor Necrosis Factor-α from Human Placental Tissues Induced by Hypoxia-Reoxygenation Causes Endothelial Cell Activation in Vitro
  163. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. I. Molecular Regulation
  164. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. II. Changes During Normal Pregnancy
  165. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. III. Changes in Complicated Pregnancies
  166. Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF
  167. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology
  168. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation
  169. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology
  170. The effect of RU486 on the gene expression profile in an endometrial explant model
  171. Antiangiogenic Agents Are Effective Inhibitors of Endometriosis
  172. Intralobular Differences in Antioxidant Enzyme Expression and Activity Reflect the Pattern of Maternal Arterial Bloodflow Within the Human Placenta
  173. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor ☆☆This study was supported by grants from the Heart and Stroke Foundation of Ontario (T-3361) and the Canadian Institutes of Health Research (MT-1502...
  174. Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17β-Estradiol in the Mouse Uterus
  175. Identification of Genes with Differential Regulation in Primate Endometrium During the Proliferative and Secretory Phases of the Cycle
  176. Generation and use of a tailored gene array to investigate vascular biology
  177. Determination of the transcript profile of human endometrium
  178. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
  179. vavCre Transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages
  180. Placental Vessel Adaptation During Gestation and to High Altitude: Changes in Diameter and Perivascular Cell Coverage
  181. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle
  182. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function
  183. Is estradiol cardioprotection a nitric oxide-mediated effect?
  184. A longitudinal study of biochemical variables in women at risk of preeclampsia
  185. Hypoxia-Reoxygenation
  186. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature*
  187. Soluble flt and the angiopoietins in the development and regulation of placental vasculature
  188. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window
  189. Large scale analysis of transcripts in human endometrium
  190. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  191. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  192. The Regulation and Localization of Angiopoietin-1, -2, and Their Receptor Tie2 in Normal and Pathologic Human Placentae
  193. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
  194. Angiogenesis and Blood Flow: Implications for Pathobiology—A Workshop Report
  195. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells
  196. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells1
  197. Placental Vascular Morphogenesis: Introduction and Overview
  198. Placental vascular morphogenesis
  199. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey
  200. Changes in Tumorigenesis- and Angiogenesis-related Gene Transcript Abundance Profiles in Ovarian Cancer Detected by Tailored High Density cDNA Arrays
  201. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium
  202. Angiogenic growth factor expression in placenta
  203. Angiogenesis in reproduction
  204. Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia1
  205. Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia
  206. The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium
  207. Alternative Splicing of Vascular Endothelial Growth Factor (VEGF)-R1 (FLT-1) pre-mRNA Is Important for the Regulation of VEGF Activity
  208. Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy1
  209. A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1
  210. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
  211. Placental angiogenesis: the role of the VEGF family of proteins
  212. Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies
  213. Expression and Localization of the Th2-type Cytokine Interleukin-13 and Its Receptor in the Placenta During Human Pregnancy
  214. The role of leukaemia inhibitory factor and interleukin-6 in human reproduction
  215. Vascular endothelial growth factor and corpus luteum angiogenesis
  216. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies
  217. VEGF mRNA Levels in Placentae From Pregnancies Complicated by Pre-Eclampsia
  218. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis
  219. Isolation of macrophages (Hofbauer cells) from human term placenta and their prostaglandin E2 and thromboxane production
  220. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium
  221. In-vivo gene transfer to the uterine endometrium
  222. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis
  223. PGE2 and TXA2 Production by Isolated Macrophages from Human Placenta
  224. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
  225. Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy
  226. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia
  227. Messenger RNA encoding thiol protein disulphide isomerase in amnion, chorion and placenta in human term and preterm labour
  228. Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum
  229. Vascular Endothelial Growth Factor (VEGF) Concentrations Are Elevated in Peritoneal Fluid of Women With Endometriosis
  230. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
  231. Expression of interleukin-13 by first trimester human villous trophoblast
  232. Hepatocyte growth factor and its receptor c-met: Localization and expression in the human placenta
  233. Localization of VEGF and expression of its receptors flit and KDR in human placenta throughout pregnancy
  234. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis
  235. Cloning, expression and genomic organization of human placental protein disulfide isomerase (previously identified as phospholipase C alpha)
  236. Expression of prostacyclin and thromboxane synthases in placenta and placental bed after pre-eclamptic pregnancies
  237. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry
  238. Stage-Specific Expression of Cytokine and Receptor Messenger Ribonucleic Acids in Human Preimplantation Embryos1
  239. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.
  240. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata
  241. Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  242. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
  243. Quantification of mRNA in Human Tissue Using Fluorescent Nested Reverse-Transcriptase Polymerase Chain Reaction
  244. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
  245. Extension of incomplete cDNAs (ESTs) by biotin/streptavidin-mediated walking using the polymerase chain reaction
  246. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
  247. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction
  248. Capture PCR: An Efficient Method for Walking Along Chromosomal DNA and cDNA
  249. Expression of mRNA for vascular endothelial growth factor in human placenta
  250. Alternatively Spliced mRNAs for Human Endothelin-2 and Their Tissue Distribution
  251. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
  252. Endothelin-2 mRNA Splice Variants Detected by RT-PCP in Cultured Human Vascular Smooth Muscle and Endothelial Cells
  253. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction
  254. [91] Fluorescent and radioactive solid-phase dideoxy sequencing of polymerase chain reaction products in microtiter plates
  255. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.
  256. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle
  257. Expression of messenger RNA for kit-ligand in human placenta: localization by in situ hybridization and identification of alternatively spliced variants
  258. Expression of messenger RNA for kit-ligand in human placenta: localization by in situ hybridization and identification of alternatively spliced variants.
  259. New protocols for DNA sequencing with dye terminators
  260. Evidence against a role for blastocyst-secreted oxytocin in early pregnancy maintenance in sheep
  261. Identification of mRNA for epidermal growth factor and transforming growth factor-α present in low copy number in human endometrium and decidua using reverse transcriptase-polymerase chain reaction
  262. Cloning and characterization of a gene encoding pig epidermal growth factor
  263. Fluorescent and radioactive solid phase dideoxy sequencing of per products in microtitre plates
  264. PCR walking from microdissection clone M54 identifies three exons from the human gene for the neural cell adhesion molecule L1 (CAM-L1)
  265. Luteal oxytocin: characteristics and control of synchronous episodes of oxytocin and PGF2α secretion at luteolysis in ruminants
  266. Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction
  267. A rapid semi-automated microtiter plate method for analysis and sequencing by PCR from bacterial stocks
  268. Nucleotide sequence of a full length cDNA clone encoding the oxytocin-neurophysin I precursor isolated from the ovine corpus luteum
  269. Concentrations of oxytocin-neurophysin prohormone mRNA in corpora lutea of sheep during the oestrous cycle and in early pregnancy
  270. The contribution of recombinant DNA techniques to reproductive biology
  271. Does the human corpus luteum synthesize neurohypophysial hormones?
  272. Linear Amplification Sequencing with Dye Terminators
  273. Working with Oxygen and Oxidative Stress In Vitro
  274. Angiogenesis and Vascular Endothelial Growth Factor (VEGF) in Reproduction